Hepion Pharmaceuticals, Inc. (CTRVP) Shareholders’ equity 2020–2023
Hepion Pharmaceuticals, Inc. (CTRVP) shareholders’ equity at each fiscal year-end, per SEC filings.
$7.3MFY2023 · since FY2020: $40.5M → $7.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $7.3M | -85.4% |
| FY2022 | $49.9M | -46.4% |
| FY2021 | $93.0M | +129.5% |
| FY2020 | $40.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTRVP financial trends
CTRVP RevenueCTRVP Net incomeCTRVP Net marginCTRVP Gross profitCTRVP Gross marginCTRVP Operating incomeCTRVP Operating marginCTRVP Operating cash flowCTRVP Free cash flowCTRVP Capital expendituresCTRVP Return on equityCTRVP Stock buybacksCTRVP Dividends paidCTRVP Total assetsCTRVP Total liabilitiesCTRVP overview →